Warning issued to patients who stop using weight-loss jabs

Health managers have raised concerns regarding the revival of patients weight After stopping popular weight loss drugs such as Wegovy And Mounjarocalling for solid support to prevent them from accumulating on books again.

THE National Institute for Excellence of Health and Care (Nice), the healthcare dog of the United Kingdom, stressed the research indicating that many people regain weight if they are not adequately supported after ceasing treatment.

Nice stressed that those who come out of drugs should be offered “structured advice and follow -up support” to mitigate weight gain.

This management applies specifically to people who receive these treatments through the NHS.

However, approximately 1.5 million people in the United Kingdom are currently using weight loss injections, the vast majority paying privately. These people will not be eligible for the support of the NHS once their treatment is completed.

Over the next three years, around 240,000 people deemed to have the “greatest need” should receive Mounjaro, also known as shooting, via NHS.

Nice’s new “quality standard” indicates that NHS patients should be monitored for at least one year after treatment, and additional support should be offered if necessary.

It emphasizes the creation of “long -term behavioral habits, to use self -surveillance tools and to rely on wider support – from online communities to family and local interventions”.

This standard, a type of advice for health services in England and Wales, defines expectations for health providers, including how they should support patients.

“Successful weight management does not stop when medicine stops or when someone ends a behavior program, “said Professor Jonathan Benger, Deputy Managing Director and chief in Nice.

“We know that the transition period after treatment is crucial and people need structured support to maintain the positive changes they have made.

“This new standard ensures that the services provide this vital continuity of care, and it supports the NHS 10 year old plan to move from an” illness service “to an authentic health service Prevention focused. »»

Dr. Rebecca Payne, chairman of the Nice quality standards advisory committee, added: “Weight management is a long -term trip, not a short -term solution.

“The evidence is clear that advice and support for the maintenance of weight after stopping medication or carrying out behavioral interventions can help prevent weight from regaining weight and allowing people to suffer lasting advantages.

“We have seen excellent examples of services that already provide full output planning and continuous support.

“This quality standard will help ensure that all health care providers adopt these best practices, giving each person the best chance of maintaining their long -term weight management success.

“This standard guarantees that health services are equipped to provide this essential support in progress.”

Commentary, Henry Gregg, Managing Director of the National Pharmacy Association, said: “Pharmacies Take their responsibilities seriously to provide full support around patients trying to achieve healthy weight.

“We know that although drugs can be effective in accelerating weight loss In some people, it is not a miracle solution and patients must make long -term lifestyle changes to make their weight loss lasting.

“The current NHS has come out of the weight loss treatment is very low, with only a handful of patients who receive it and will continue to be the case that the vast majority of eligible patients will be seen by their pharmacy.”

Professor Kamila Hawthorne, president of the Royal GPS CollegeSaid: “There is no unique approach to fighting obesity – what works for a patient will probably not work for another and, as for any medication, weight loss drugs do not come without risk.

“It is also true that patients will probably need support to maintain their weight loss once they have stopped taking the medication. As such, it is an important and sensible orientation of Nice.

“As a college, we have been clear that, although weight loss drugs have important potential advantages for patients who have trouble losing weight, they should not be considered as a miracle solution” and guarantee access to sufficient services of “ enveloping ” – in particular at the time when patients withdraw their medications – will be essential to optimal results. »»